Richwood Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$742K Sell
5,873
-285
-5% -$37.6K 0.52% 44
2026
Q1
$858K Sell
6,158
-35
-0.6% -$4.9K 0.66% 35
2025
Q4
$944K Sell
6,193
-315
-5% -$38.3K 0.68% 36
2025
Q3
$722K Sell
6,508
-50
-0.8% -$5.68K 0.57% 40
2025
Q2
$727K Sell
6,558
-175
-3% -$18.6K 0.6% 39
2025
Q1
$754K Sell
6,733
-80
-1% -$8.26K 0.64% 40
2024
Q4
$629K Sell
6,813
-20
-0.3% -$1.8K 0.52% 48
2024
Q3
$573K Sell
6,833
-380
-5% -$29K 0.47% 54
2024
Q2
$495K Sell
7,213
-2,040
-22% -$136K 0.43% 59
2024
Q1
$678K Sell
9,253
-440
-5% -$33.8K 0.6% 44
2023
Q4
$785K Sell
9,693
-418
-4% -$32.5K 0.74% 32
2023
Q3
$758K Buy
10,111
+380
+4% +$29.2K 0.77% 32
2023
Q2
$750K Buy
9,731
+150
+2% +$12K 0.73% 35
2023
Q1
$795K Hold
9,581
0.79% 32
2022
Q4
$823K Buy
9,581
+195
+2% +$15.4K 0.83% 29
2022
Q3
$579K Buy
9,386
+210
+2% +$13.2K 0.64% 43
2022
Q2
$567K Buy
9,176
+285
+3% +$17.6K 0.57% 47
2022
Q1
$529K Buy
8,891
+2,090
+31% +$134K 0.47% 61
2021
Q4
$494K Buy
+6,801
New +$468K 0.43% 56

Other funds holding GILD

Richwood Investment Advisors's GILD Position: Q2 2026 in Review

Richwood Investment Advisors reduced its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, selling an estimated $37.6K and leaving 5,873 shares worth $742K. The position accounts for 0.52% of the portfolio, ranked #44.

Richwood Investment Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $944K in Q4 2025. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Richwood Investment Advisors held 5,873 shares of Gilead Sciences worth $742K as of Q2 2026.
  • Richwood Investment Advisors sold 285 Gilead Sciences shares in Q2 2026, an estimated $37.6K.
  • Gilead Sciences made up 0.52% of Richwood Investment Advisors's portfolio in Q2 2026, its #44 holding.
  • Richwood Investment Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Richwood Investment Advisors's Gilead Sciences position peaked at $944K in Q4 2025.
  • 965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Richwood Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.